Brian Burchell Selected Research

NU-ICRF 505

5/2006	Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
2/2002	Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian Burchell Research Topics

Disease

3	Colonic Neoplasms (Colon Cancer) 05/2006 - 02/2002
2	Colorectal Neoplasms (Colorectal Cancer) 05/2006 - 02/2002
2	Neoplasms (Cancer) 12/2003 - 01/2003
1	Hepatocellular Carcinoma (Hepatoma) 12/2006
1	Cholestasis 01/2003

Drug/Important Bio-Agent (IBA)

2	Uridine Diphosphate (UDP)IBA 12/2006 - 12/2003
2	NU-ICRF 505IBA 05/2006 - 02/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2006 - 02/2002
2	Pharmaceutical PreparationsIBA 12/2003 - 01/2003
2	Topoisomerase I InhibitorsIBA 12/2003 - 02/2002
1	AcetylglucosamineIBA 12/2006
1	Uridine Diphosphate Glucuronic Acid (UDP Glucuronic Acid)IBA 12/2006
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	Food Additives (Food Additive)IBA 12/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2003
1	IsoenzymesIBA 12/2003
1	Bile Acids and Salts (Bile Acids)IBA 01/2003
1	XenobioticsIBA 01/2003
1	SteroidsIBA 01/2003
1	Tyrosine (L-Tyrosine)FDA Link 02/2002
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2002
1	trioctyl phosphine oxide (TOPO)IBA 02/2002
1	AnthraquinonesIBA 02/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 05/2006 - 12/2003